Back to Homepage
Do transplantation patients need anti-rejection treatment for life?
Anti-rejection medication, also known as immunosuppressants, plays a crucial role in ensuring the long-term survival and function of the transplanted organ.
They achieve this by preventing the recipient’s immune system from recognizing and attacking the transplanted organ, a phenomenon known as rejection.
Patients undergoing liver transplantation will need anti-rejection treatment for the rest of their lives.
There are several key aspects of anti-rejection treatment to be aware of. First and foremost, regular follow-up appointments, and monitoring through blood work are essential to assess the effectiveness of anti-rejection treatment and detect any sign of rejection or side effects.
The medication regimen is adjusted in the months and years following transplantation with dosing levels and specific medication changing based on the patient response and the risk of rejection.
Additionally, decreasing the dose of anti-rejection drugs is important to minimize their side effects.
With proper care including regular medical follow up the appearance to medication and healthy lifestyle, many liver transplant recipients can achieve excellent long-term outcomes and enjoy a fantastic quality of life.
